1. Home
  2. EVO vs UMH Comparison

EVO vs UMH Comparison

Compare EVO & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • UMH
  • Stock Information
  • Founded
  • EVO 1993
  • UMH 1968
  • Country
  • EVO Germany
  • UMH United States
  • Employees
  • EVO N/A
  • UMH N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • UMH Real Estate Investment Trusts
  • Sector
  • EVO Health Care
  • UMH Real Estate
  • Exchange
  • EVO Nasdaq
  • UMH Nasdaq
  • Market Cap
  • EVO 1.5B
  • UMH 1.4B
  • IPO Year
  • EVO 2021
  • UMH N/A
  • Fundamental
  • Price
  • EVO $4.34
  • UMH $17.15
  • Analyst Decision
  • EVO Buy
  • UMH Strong Buy
  • Analyst Count
  • EVO 2
  • UMH 4
  • Target Price
  • EVO $5.90
  • UMH $21.00
  • AVG Volume (30 Days)
  • EVO 120.0K
  • UMH 539.9K
  • Earning Date
  • EVO 08-13-2025
  • UMH 08-06-2025
  • Dividend Yield
  • EVO N/A
  • UMH 5.28%
  • EPS Growth
  • EVO N/A
  • UMH N/A
  • EPS
  • EVO N/A
  • UMH 0.10
  • Revenue
  • EVO $851,944,444.00
  • UMH $243,777,000.00
  • Revenue This Year
  • EVO $10.08
  • UMH $10.60
  • Revenue Next Year
  • EVO $10.99
  • UMH $7.76
  • P/E Ratio
  • EVO N/A
  • UMH $164.16
  • Revenue Growth
  • EVO 1.50
  • UMH 8.17
  • 52 Week Low
  • EVO $2.84
  • UMH $15.74
  • 52 Week High
  • EVO $5.64
  • UMH $20.64
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.99
  • UMH 55.22
  • Support Level
  • EVO $4.15
  • UMH $16.49
  • Resistance Level
  • EVO $4.33
  • UMH $17.04
  • Average True Range (ATR)
  • EVO 0.11
  • UMH 0.36
  • MACD
  • EVO 0.02
  • UMH 0.04
  • Stochastic Oscillator
  • EVO 85.92
  • UMH 93.15

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

Share on Social Networks: